The Conference will organise an exchange of information and best practices on key aspects of the European Innovation Partnership on Active and Healthy Ageing in the fields of Integrated care, Prevent...
The Conference will organise an exchange of information and best practices on key aspects of the European Innovation Partnership on Active and Healthy Ageing in the fields of Integrated care, Prevention, Dementia friendly society and Innovative solutions.
The Conference is also in line with the areas singled out in the Commission Communication on a European initiative on Alzheimer`s disease for greater EU collaboration, namely 1. Acting early to diagnose dementia, 2. A shared European effort in research, 3. National solidarity and exchange of best care practices, 4. Respecting the rights of people with dementia.
In order to support the actions outlined in the Innovation Partnership and the Commission Communication, the 23rd AE Conference will focus on these four priorities and organise an exchange of information, experiences, projects and best practices in the following areas:
1. Integrated care (Post diagnostic support, care in the community, carer training, residential care), 2. Prevention (Preventing dementia, behavioural problems, carer burnout and hospitalisation), 3. Dementia friendly society (Dementia friendly communities, Dementia strategies, Perceptions and image of dementia, Ethical and legal aspects), 4. Innovative solutions (Assistive technologies, dementia and the arts, new psychosocial approaches, involvement of people with dementia).
In all areas, AE will identify keynote speakers to provide state of the art presentations on the current knowledge and understanding, whilst inviting presenters to submit abstracts on ongoing and recently finalised research, projects and experiences.
In addition, AE will collaborate with EU funded initiatives to share the progress and results of research initiatives of programmes and projects like the Joint Programming Initiative on Neurodegenerative Disease, the Joint Action (ALCOVE-Alzheimer COoperation and Valuation in Europe), projects supported under the FP7 and AAL Programmes and by the Innovative Medicines Initiative (PharmaCog).